Status:
COMPLETED
Ahmed Glaucoma Valve and Single-Plate Molteno Implants in Treatment of Refractory Glaucoma
Lead Sponsor:
Vanak Eye Surgery Center
Conditions:
Refractory Glaucoma
Eligibility:
All Genders
40+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to investigate the efficacy and safety of the Ahmed valve implant (AVI) and the Molteno single-plate implant (MSPI) in eyes with refractory glaucoma during a follow-up per...
Eligibility Criteria
Inclusion
- refractory glaucoma, defined as uncontrolled IOP despite maximal anti-glaucoma medication, previously failed nonseton surgical treatment, or a combination thereof.
Exclusion
- age less than 40 years
- a visual acuity of no light perception
- lens opacity
- elevated IOP associated with silicone oil previous glaucoma drainage device implantation in the same eye
- previous cyclodestructive treatment
- increased risk of endophthalmitis posterior segment disorders
- pre-existing ocular comorbidities.
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2005
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT00971061
Start Date
January 1 2003
End Date
August 1 2005
Last Update
September 4 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanak Eye Surgery Center
Tehran, Tehran Province, Iran